Antibody Studio (ABS) has successfully licensed multiple bi/tri-specific antibody assets and completed multiple partner projects. Recent collaborations, including a partnership with Candid Therapeutics to develop novel T cell engagers (TCE) for autoimmune (I&I) indications, reflect our dedication to help our Partners advance innovative therapies for diseases with significant unmet medical needs.